Plug Power (NASDAQ:PLUG) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Thursday, American Banking News reports. The firm currently has a $7.90 price objective on the stock. Zacks‘s target price would suggest a potential upside of 8.37% from the company’s current price. Plug Power Inc (NASDAQ:PLUG) shares after opening at $7.40 moved to $7.48 on last trade day and at the end of the day closed at $6.99. Company price to sales ratio in past twelve months was calculated as 41.04 and price to cash ratio as 91.41. Plug Power Inc (NASDAQ:PLUG) showed a negative weekly performance of -3.05%.
The company on Apr. 2 announced the appointment of Hugh M. Cole to the position of senior vice president and chief business officer. Mr. Cole will be responsible for global business and corporate development, licensing and strategic planning. He will report to Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s chairman and chief executive officer, Harvey J. Berger, M.D. Mr. Cole is a seasoned pharmaceutical executive with more than 25 years of industry experience and a deep background in rare and orphan pharmaceutical markets. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -4.70% in last trading session and ended the day on $6.69. ARIA return on equity ratio is recorded as-98.50% and its return on assets is -65.80%. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) yearly performance is -62.48%.
Speculators have bought to open puts, relative to calls, at a near-annual-high pace in Canadian Solar Inc. (NASDAQ:CSIQ) options pits during the past two weeks, as evidenced by the stock’s 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.72, which ranks just 10 percentage points from a 12-month peak. This comes as no surprise, considering CSIQ shares have lost 40% over the past three months to trade at $25.17. Not to mention, Schaeffer’s Volatility Index (SVI) for Canadian Solar Inc. comes in at 74%, in the bottom quartile of its annual range, indicating short-term options are cheaper than usual right now, from a volatility perspective. Canadian Solar Inc. (NASDAQ:CSIQ) shares moved down -2.44% in last trading session and was closed at $25.17, while trading in range of $23.01 – 26.22. Canadian Solar Inc. (NASDAQ:CSIQ) year to date (YTD) performance is -15.59%.
Novavax, Inc. (NASDAQ:NVAX) is a $805 million biotech that develops vaccines for a number of diseases. The stock is currently in a pullback, but this is not surprising because it is happening everywhere in the healthcare sector. But even so, the pullback in Novavax only creates a buying opportunity for long-term outlook investors. Novavax, Inc. (NASDAQ:NVAX) weekly performance is -14.58%. On last trading day company shares ended up $3.69. Novavax, Inc. (NASDAQ:NVAX) distance from 50-day simple moving average (SMA50) is -29.67%. Analysts mean target price for the company is $11.20.
Leave a Reply